Nicoxamat
- Level
- Commodity
- Parent
- 51192000
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51192012This classification denotes a uricosuric agent with the molecular formula C6H6N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z3H2D4MF7A, chemically known as 3-pyridinecarboxamide, n-hydroxy- but generally known as nicoxamat, which bears US NIH Compound Identifier 71211. European Medicines Agency schedules Nicoxamat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09249MIG. The term NICOXAMAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). NICOXAMAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nicoxamat under HS 29333999 and SITC 51574. As of Q4 2014, NICOXAMAT remains the US FDA Preferred Term for this commodity. Nicoxamat bears US NLM identifiers UMLS ID C2698465 and NCI Concept Code C77068. SMILES: O=C(NO)C1CCCNC1.
Same parent
Under 51192000 · 21Activities that produce or sell this
KBLI · 9Inherited from family 51190000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.